Back to search

United Kingdom· GB-APID-14654011000001104

Rifadin 300mg capsules

A rifampicin product containing rifampicin, registered in United Kingdom by Sigma Pharmaceuticals Plc. The same ATC class is registered in 18 of our 19 countries.

ATC J04AB02

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRifadin 300mg capsulesATCJ04AB02REGISTER NO.GB-APID-1465401100000…PACKS LISTED0CHECKEDSeptember 13, 2026

Where it is registered

Rifampicin is registered in 18 of 19 countries.

Countries holding a registration under ATC J04AB02 (rifampicin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 10 of them publish a price we can compare per daily dose

Rifampicin · ATC J04AB02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rifampicin costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.92 in Italy to $6.35 in France — a ×6.9 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Rifampicin · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • FR France$6.35
  • CH Switzerland$4.70
  • IT Italy$0.92
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Rifampicin
Manufacturer
Sigma Pharmaceuticals Plc
Country
United Kingdom (GB)
ATC code
J04AB02
ATC class
Rifampicin
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

444 interactions on record for rifampicin.

Graded by severity as the source publishes them — 144 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Rifampicin · interactions on record

444 records

  • 144 severe
  • 173 moderate
  • 14 minor
  • 39 info

Most severe, free to view

  • RolapitantA04AD14severe
  • NaloxegolA06AH03severe
  • NaldemedineA06AH05severe
  • EluxadolineA07DA06severe

74 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifampicin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifampicin products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Eremfat, Rifoldin
  • Belgium · Rifadine, Rifadine I. V.
  • Bulgaria · Тубоцин
  • Cyprus · Rifasynt, Syntoren
  • Czechia · Benemicin
  • Germany · Eremfat, Eremfat I.V.
  • Denmark · Rimactan
  • Spain · Rifaldin, Rimactán
  • Finland · Rimapen
  • France · Rifadine, Rifadine Iv
  • Croatia · Rimactan
  • Hungary · Rifamed
  • Ireland · Rifadin, Rifadin Intravenous
  • Iceland · Rimactan
  • Italy · Rifadin
  • Lithuania · Benemicin
  • Luxembourg · Rifadine
  • Latvia · Benemicin
  • Malta · Rifampicyna Tzf
  • Netherlands · Rifadin, Rifampicine Sandoz
  • Norway · Rimactan
  • Poland · Rifampicyna Tzf
  • Portugal · Rifadin, Rimactán
  • Romania · Rifampicină Arena, Sinerdol
  • Sweden · Rimactan
  • Slovakia · Benemicin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e266ebab-e103-4012-b477-6306fd319bf2
GET /v1/drugs/e266ebab-e103-4012-b477-6306fd319bf2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "14654011000001104",
  "desc": "Rifadin 300mg capsules (Sigma Pharmaceuticals Plc)",
  "form": "Oral capsule",
  "vpid": "41954711000001106",
  "source": "dmd",
  "vtm_id": "777438009",
  "strength": "300 mg",
  "substance": "Rifampicin",
  "ingredient": "Rifampicin",
  "supplier_code": "2087601000001106"
}

See everything about rifampicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.